Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 46 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patient’s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The firm has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.
Mr. Waqaas Al-Siddiq est le Chairman of the Board de Biotricity Inc, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action BTCY ?
Le prix actuel de BTCY est de $0.2464, il a diminué de 1.38% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Biotricity Inc ?
Biotricity Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Biotricity Inc ?
La capitalisation boursière actuelle de Biotricity Inc est de $6.8M
Est-ce que Biotricity Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Biotricity Inc, y compris 0 achat fort, 0 achat, 3 maintien, 1 vente et 0 vente forte